Triazolopyridines and triazolopyrazines as LSD1 inhibitors
First Claim
Patent Images
1. A method of treating cancer comprising administering to a patient a therapeutically effective amount of a compound of Formula IVa:
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to [1,2,4]triazolo[4,3-a]pyridine and [1,2,4]triazolo[4,3-a]pyrazine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
93 Citations
21 Claims
- 1. A method of treating cancer comprising administering to a patient a therapeutically effective amount of a compound of Formula IVa:
Specification